Dr. Eric Daar presents highlights and daily summaries from the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil. (held July 24-27 2005)
Index to the Daily Updates at the HIV / AIDS Conference
Wednesday, July 27, 2005 (Installment #3) - Read and listen to Dr. Daar
- Simplyfying Therapy
- Single Drug Treatment Caution
- Other Important Studies with Lopinavir / Ritonavir
- New Regimens and Side Effect Profiles
- New Drug - Reverset
- Read and hear (audio medical podcast) Dr. Daar's third and final installment from the conference.
Tuesday, July 26, 2005 (Installment #2) - Read and listen to Dr. Daar
- Genetic Factors and HIV.
- Antiretroviral Therapy and Drug Resistance (CCR5 Blockers, T-20, and others)
- Read and hear (audio medical podcast) Dr. Daar's second installment from the conference.
Monday, July 25, 2005 (Installment #1) - Read and listen to Dr. Daar
- Diversity of HIV strains from around the world - recombination, co-infection, and superinfection.
- Growing epidemics of HIV, particularly in Eastern Europe.
- Presentation by Dr. Blick on "Patient zero: The Connecticut source of the multi-drug resistant dual-topic, rapidly progressing HIV-1 strain found in New York City."
- Increasing transmission of drug resistant virus.
- Read and hear (audio medical podcast) Dr. Daar's first installment from the conference.
Daily Updates from Dr. Daar:
- #1 HIV / AIDS Conference - July 25, 2005 (Details)
- #2 HIV / AIDS Conference - July 26, 2005 (Details)
- #3 HIV / AIDS Conference - July 27, 2005 (Details)
About the 3rd International AIDS Society Conference
The scientific programme of the 3rd IAS Conference on HIV Pathogenesis and Treatment aims to provide new insights into HIV disease development, prevention and care that can lead to new research directions, help advance translational research and move theoretic advances into clinical practice and prevention programmes. The Programme Committee is dedicated to ensuring that the content will be relevant to today's questions including addressing the challenges of expanding treatment in resource limited settings. An additional priority is ensuring that the presentations focus on the latest HIV science and its practical applications for public and individual health in the context of where the epidemic will be in 2005. For more information visit the conference website: http://www.ias-2005.org